GERN vs LH · rev $109.3M vs P/E 23, rev $13.95B
Geron Corporation (GERN) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Geron Corporation (GERN) is a biotechnology company listed on US.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported GERN revenue for 2026-06-30 was $109.3M. Net income was -$20.3M. GERN currently screens at market cap $878.9M.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
GERN currently screens at market cap $878.9M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the GERN and LH stock pages for the full models.
Not investment advice.